par Blocklet, Didier
;Toungouz Nevessignsky, Michel
;Berkenboom, Guy
;Lambermont, Micheline
;Unger, Philippe
;Preumont, Nicolas
;Stoupel, Eric
;Egrise, Dominique
;Degaute, Jean-Paul
;Goldman, Michel
;Goldman, Serge 
Référence Stem cells, 24, 2, page (333-336)
Publication Publié, 2006-02











Référence Stem cells, 24, 2, page (333-336)
Publication Publié, 2006-02
Article révisé par les pairs
Résumé : | Granulocyte--colony-stimulating factor administered for autologous hematopoietic stem cell isolation from blood may favor restenosis in patients implanted after acute myocardial infarction (AMI). We therefore tested the isolation of peripheral-blood CD34+ cells without mobilization in six patients with AMI. After large-volume cytapheresis and positive CD34+ cell selection, 3.6 to 27.6 million CD34+ cells were obtained. We performed intra-coronary implantation of these cells and recorded no restenosis or arrhythmia. We used positron emission tomography (PET) to assess myocardial-labeled CD34+ cell homing, which accounted for 5.5% of injected cells 1 hour after implantation. In conclusion, large amounts of CD34+ cells, in the range reported in previous studies, can be obtained from nonmobilized peripheral blood. PET with [18F]-fluorodeoxyglucose cell labeling is an efficient imaging method for homing assessment. |